2020
DOI: 10.22541/au.159969827.70125804
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Variability of pharmacogenomic information in drug labels approved by different agencies and its ethical implications

Abstract: Rationale, aims and objectives: The efficacy and safety of drugs can be improved by rational prescription and personalization of medicine for each patient. Pharmacogenomics information (PGx) in drug labels (DL) is important for the personalization of medications because genetic differences may affect both drug efficacy and safety. Providing adequate PGx to patients has ethical implications. The aim of this study was to determine if there are discrepancies among various agency-approved labels for the same activ… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 25 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?